Skip to content
Evofem Biosciences, Inc.
About Us
Mission
Management
Board of Directors
Saundra Pelletier
KIM P. KAMDAR, Ph.D.
Tony O’Brien
Lisa Rarick, MD, FACOG
Colin Rutherford
Our Products
phexxi
®
Solosec
®
Publications
Investors
Investor Overview
Events & Presentations
Press Releases
Stock Information
Financial Information
SEC Filings
Analyst Coverage
Corporate Governance
Committee Composition
Board of Directors
Charters + Code of Ethics
Investor Resources
Investor Contact
Investor FAQs
Contact
Investor Contact
Media Contact
General Contact
Careers
Amphora vaginal gel: An on-demand contraceptive with anti-STI (MPT) potential
Post navigation
Previous:
Gynecologic infections and colposcopy fidings from a phase 3 efficacy and safety study of a contracpetive vaginal gel compared with nonoxynol-9
Next:
A randomized, placebo-controlled pilot study to determine the effect and duration of Acidfrom gel (Amphora) on vaginal pH
Back
to
Top
